These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 498702)

  • 21. Comparison of ceftazidime and cefamandole pharmacokinetics and blister fluid concentrations.
    Armstrong GC; Wise R; Brown RM; Hancox J
    Antimicrob Agents Chemother; 1981 Sep; 20(3):356-8. PubMed ID: 7030200
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics and hemodialyzability of cefazolin in uremic patients.
    Craig CP; Rifkin SI
    Clin Pharmacol Ther; 1976 Jun; 19(6):825-9. PubMed ID: 773590
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Studies on the diffusion rate of cefamandole in various human tissue (author's transl)].
    Plaue R; Müller O; Fabricius K; Bethke RO
    Arzneimittelforschung; 1978; 28(12):2343-9. PubMed ID: 582953
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Kinetics and renal handling of cefonicid.
    Pitkin D; Dubb J; Actor P; Alexander F; Ehrlich S; Familiar R; Stote R
    Clin Pharmacol Ther; 1981 Nov; 30(5):587-93. PubMed ID: 7297018
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacology of ceftizoxime compared with that of cefamandole.
    Neu HC; Srinivasan S
    Antimicrob Agents Chemother; 1981 Sep; 20(3):366-9. PubMed ID: 6272631
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hydrolysis of cefamandole nafate in dialysis patients.
    Nielsen RL; Wolen R; Luft FC; Ozawa T
    Antimicrob Agents Chemother; 1979 Nov; 16(5):683-5. PubMed ID: 526012
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A study of the diffusion of cefamandole into bronchial secretions (author's transl)].
    Bergogne-Berezin E; Berthelot G; Even P
    Nouv Presse Med; 1981 Jun; 10(25):2089-91. PubMed ID: 7267304
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Netilmicin pharmacokinetics in uremic patients undergoing hemodialysis.
    Scatizzi A; Basile C; Strippoli P; Di Maggio A; Orbello G; Lodeserto C; Triarico A; Mingrone G; Longo S; Curino E
    Chemioterapia; 1986 Oct; 5(5):327-9. PubMed ID: 3791480
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cefamandole: pharmacokinetics and therapeutic evaluation in urology.
    Zinati AH; Naber KG
    Arzneimittelforschung; 1980; 30(5):839-42. PubMed ID: 7190432
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics of cefamandole in rabbits with experimentally induced renal impairment.
    Campillo JA; Dominguez-Gil AA; Cepeda M; Dominguez-Gil A
    J Antibiot (Tokyo); 1980 Mar; 33(3):322-7. PubMed ID: 7380743
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biliary concentrations of cefamandole and its use in biliary tract surgery.
    Levi JU; Livingstone AS; Martinez OV; Zeppa R; Malinin T; Hutson DG; Einhorn NC
    Scand J Infect Dis Suppl; 1980; suppl 25():55-7. PubMed ID: 6782654
    [No Abstract]   [Full Text] [Related]  

  • 32. Pharmacokinetics of the cephalosporins in healthy volunteers and uremic patients.
    Kirby WM; De Maine JB; Serrill WS
    Postgrad Med J; 1971 Feb; 47():Suppl:41-6. PubMed ID: 5556189
    [No Abstract]   [Full Text] [Related]  

  • 33. Pharmacokinetics and safety of cefamandole in newborn infants.
    Agbayani MM; Khan AJ; Kemawikasit P; Rosenfeld W; Salazar D; Kumar K; Glass L; Evans HE
    Antimicrob Agents Chemother; 1979 May; 15(5):674-6. PubMed ID: 525985
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Observations in man on some pharmacologic features of cefamandole.
    Grose WE; Bodey GP; Stewart D
    Clin Pharmacol Ther; 1976 Nov; 20(5):579-84. PubMed ID: 975730
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics of intravenous cefotaxime in patients undergoing chronic hemodialysis.
    Chodos J; Francke EL; Saltzman M; Neu HC
    Ther Drug Monit; 1981; 3(1):71-4. PubMed ID: 6262952
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics of cefonicid, a new broad-spectrum cephalosporin.
    Barriere SL; Hatheway GJ; Gambertoglio JG; Lin ET; Conte JE
    Antimicrob Agents Chemother; 1982 Jun; 21(6):935-8. PubMed ID: 7114840
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Moxalactam pharmacokinetics during hemodialysis.
    Aronoff GR; Sloan RS; Mong SA; Luft FC; Kleit SA
    Antimicrob Agents Chemother; 1981 Apr; 19(4):575-7. PubMed ID: 6454386
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interaction of cephalosporins with human and canine serum proteins.
    Peterson LR; Gerding DN
    J Infect Dis; 1978 Apr; 137(4):452-7. PubMed ID: 649989
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics of cefamandole in patients with normal and impaired renal function.
    Mellin HE; Welling PG; Madsen PO
    Antimicrob Agents Chemother; 1977 Feb; 11(2):262-6. PubMed ID: 848932
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hydrolysis of cefamandole nafate to cefamandole in vivo.
    Wold JS; Joost RR; Black HR; Griffith RS
    J Infect Dis; 1978 May; 137 Suppl():S17-S24. PubMed ID: 650001
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.